Cleveland Research recommends avoiding shares of Panera Bread Cleveland Research continues to see risk to its Panera Bread 2% comp estimate for the year and expects higher food inflation, investments, unclear timing and benefits of Panera 2.0 and limited pricing power to pressure earnings over the next two years. Shares are Neutral rated.
Panera Bread downgraded to Hold on valuation at Wunderlich Wunderlich downgraded Panera Bread to Hold from Buy with shares within 8% of its unchanged price target of $185. The firm still expects Panera's same-store sales to continue to improve thru 2015 and 2016.
Hain Pure Protein extends relationship with Panera Bread The Hain Celestial Group (HAIN) announced that Hain Pure Protein has entered into a new supply agreement with Panera (PNRA) to provide Plainville Farms turkey breast meat raised without antibiotics to Panera Bread. HPPC has been supplying Panera Bread with turkey raised without antibiotics on family farms since 2011.